Sinziana Avramescu Selected Research

Adrenergic Agonists (Adrenergic Receptor Agonist)

1/2018

Dexmedetomidine Prevents Excessive γ-Aminobutyric Acid Type A Receptor Function after Anesthesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sinziana Avramescu Research Topics

Disease

2	Delirium 01/2018 - 11/2017
2	Inflammation (Inflammations) 02/2016 - 09/2012
2	Seizures (Absence Seizure) 01/2016 - 04/2006
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Neurocognitive Disorders (Clerambault Syndrome) 12/2018
1	Critical Illness (Critically Ill) 02/2016
1	Hemorrhage 01/2016
1	Memory Disorders (Memory Loss) 09/2012
1	Chronic Disease (Chronic Diseases) 07/2008
1	Brain Ischemia (Cerebral Ischemia) 04/2006

Drug/Important Bio-Agent (IBA)

4	Aminobutyrates (Aminobutyric Acid)IBA 01/2020 - 09/2012
2	Dexmedetomidine FDA Link 01/2018 - 11/2017
2	General AnestheticsIBA 01/2018 - 02/2016
1	L 655,708IBA 01/2020
1	CytokinesIBA 01/2020
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	LipopolysaccharidesIBA 02/2016
1	InterleukinsIBA 02/2016
1	Anesthetics (Anesthetic Agents)IBA 02/2016
1	Tranexamic Acid (AMCA)FDA Link 01/2016
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2016
1	Ketamine FDA LinkGeneric 07/2008
1	Xylazine (Xylazin)IBA 07/2008
1	Kainic Acid (Kainate)IBA 04/2006

Therapy/Procedure

1	Anesthesia 12/2018
1	Length of Stay 01/2016